A cheeky website about deals, dealmakers and anything else I find interesting. Edited by Ben Harrington. If you have a tip or want to discuss a story please feel free to email Betaville at ben@betaville.co.uk. Betaville can also be reached at Whats App, Signal or Telegram. Betaville's Twitter handle is @bharringtonw11 and you can message me via Twitter with stories.

Saturday review

Saturday, 27 February 2016, 9:45 pm

There were plenty of interesting nuggets in the today's business sections...

Read more...

Coincidence? - returns

Friday, 26 February 2016, 9:24 pm

Here's an interesting snippet - Flowserve, the US pump manufacturer, yesterday abruptly cancelled plans to present at Gabelli's 26th Annual Pump, Valve and Water Systems Symposium in New York...

Read more...

Panmure Gordon shenanigans

Wednesday, 24 February 2016, 11:39 pm

So, I was just about to publish a story about how Phillip Wale, chief executive of Panmure Gordon, has held talks with rival brokers about merging when the company stuck this statement out:..

Read more...

Flag pole alert - part 7

Tuesday, 23 February 2016, 9:16 pm

Readers might recall the heightened speculation towards the back end of last year about British American Tobacco weighing a £50 billion break up takeover bid for Imperial Tobacco, now called Imperial Brands...

Read more...

A man and his view...

Thursday, 18 February 2016, 9:07 pm

It's a good to see another one man band provoke a statement from a multi-billion dollar company...

Read more...

Village gossip - Sandell Asset Management founder said to be planning to move to the UK

Thursday, 18 February 2016, 5:26 am

Thomas Sandell, the founder of one Europe's original "event driven" investment firms, could be about   to move old Blighty.

City sources told little Betaville that Sandell has indicated to friends and colleagues he is planning to move to London from New York.

For readers unfamiliar with Sandell, he is well-know among London's hedgies for setting up Sandell as an "event driven" fund that also pursues "activism" in 1998...

Read more...

Village gossip - top British dealmaker quits Canaccord Genuity for Macquarie

Sunday, 14 February 2016, 6:25 am

So, I alluded to a major departure from Canaccord Genuity last week and now I have finally bottomed out the tale.

I understand Jacques Callaghan, one of the City of London's leading investment bankers, has left the beleaguered Canadian outfit for Australian investment bank Macquarie.

From what I can tell. he left Canaccord Genuity a couple of weeks ago and wasn't part of last week's cull...

Read more...

Canacord Genuity wields the axe - part 2

Friday, 12 February 2016, 9:53 pm

Canacord Geniuty appears to have tacitly confirmed my tale from earlier in the week.

In case you missed it, the broker/investment bank released dire 3rd quarter results this morning, announcing there would be a major "restructuring" resulting in job losses in the UK and elsewhere.

Here is a link to today's press release:..

Read more...

Another day, another multi-billion pharma deal - the series returns!

Friday, 12 February 2016, 4:56 am

I have to admit I was surprised to see US generic drugs giant Mylan return for Nordic group Meda given the market turbulence and general carnage in biotech share prices.

Hat tip, though, to the Financial Times for landing the scoop last night about the $9.9 billion takeover deal.

And I hear another Financial Times pharma takeover scoop might be about to come good. ..

Read more...

Canaccord Genuity wields the axe

Wednesday, 10 February 2016, 5:00 pm

Here is a tale to add to the doom and gloom that has descended upon financial markets since the beginning of the year.

It would appear there has been a bit of a cull over at Canaccord Genuity, the Canadian stockbroker that has been gobbling up British brokers in the last couple of years.

I'm told by sources that over 30 of Canaccord's UK staff were booted out yesterday - that's almost 10pc of the company's British workforce. ..

Read more...

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].